FindTrial
Sign In

Early Recovery After Keyhole/Robot-Assisted Direct Heart Bypass Surgery Compared to Traditional Off-Pump Heart Bypass: A Real-World Observation Study

Early Outcome after Minimally Invasive/Robotic assisted direct coronary artery bypass versus Off-pump coronary artery bypass surgery - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110313
Enrollment
100
Registered
2026-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery Health Condition 2: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: Nil: Nil

Sponsors

Institutional Research Committee SGPGI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for off pump coronary artery bypass surgery either minimally invasive or robotic-assisted and direct coronary having Double or triple vessel disease posted for primary and isolated CABG with normal Carotid Doppler.

Exclusion criteria

Exclusion criteria: Patients with end-stage kidney disease with low estimated glomerular filtration rate or requiring dialysis A history of previous cardiac surgery Congenital heart disease Atrial Fibrillation Severe Pulmonary Hypertension Active or chronic inflammatory or autoimmune diseases and steroid therapy Who don t give consent for the study Severe pulmonary hypertension Deranged coagulation profile Recent heart failure Uncontrolled Diabetes or Hypertension

Design outcomes

Primary

MeasureTime frame
Incidence of major adverse cerebro-cardiovascular events (MACCE), including all-cause mortality, non-fatal MI, stroke or transient ischemic attack, and the need for repeat revascularization (percutaneous coronary intervention or redo-CABG) in the immediate or early post operative period (with in 7 days )Timepoint: First and Second Year: Patient enrolment and sample and data collection The collected serum samples will be snap-frozen in liquid nitrogen and subsequently stored at -80 C before analysis. Third year -Analysis—

Secondary

MeasureTime frame
Days of discharge from ICU, presence organ dysfunction with biomarkers & haematological marker observing inflammatory pattern during ICU stay & early post operative period (7 days) , renal failure after surgery, post operative wound infection & pain score.Timepoint: Marker will be taken at 4 time points namely T1 Baseline followed by T2 immediate post graft postoperative day 0 then post operative day 3 finally postoperative day 4—

Countries

India

Contacts

Public ContactAmit Rastogi

Sanjay Gandhi Post Graduate Institute of Medical Sciences

amit.rastogi.sgpgi@gmail.com9793124468

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026